Dialectical behavior therapy (DBT) appears to be a feasible and acceptable therapy to help with mood regulation in those with bipolar disorder.
A new study reports different subtypes of bipolar disorder tend to cluster within families, suggesting that even though there are genetic similarities that indicate overlap between subtypes, each has a different origin.
A new post-mortem study identified significant differences in gene expression in two brain areas in patients with bipolar disorder.
Typically, many people associate depression with feelings of sadness or despair. However, depression can also affect your cognitive abilities and memory. A new paper reviews the impact depression has on cognitive function and considers therapy options to help improve these often overlooked symptoms of the disorder.
Teens with psychosis spectrum disorders have significantly reduced surface areas in the orbitofrontal cortex, cingulate, precentral, and postcentral brain regions. MRI scans also revealed decreased thalamic volume.
Neuroimaging study identifies differences in cerebral white matter in bipolar patients who do not take lithium.
According to a new study, genes linked to creativity could also increase the risk of developing some psychiatric disorders.
Following a 12 year long study, researchers have identified seven phenoclasses that can help doctors to diagnose and track the progression of bipolar disorder in patients.
Elevated glycine levels are associated with the onset of psychosis, a new study reports.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.
Comparing data from multiple neuroimaging studies, researchers found shared brain structural abnormalities between four psychiatric disorders, including schizophrenia and bipolar disorder. They also identified brain signatures unique to each condition.
Researchers report the CPG2 protein is significantly decreased in the brains of people with bipolar disorder and mutations in the SYNE1 gene undermines the expression of CPG2. The study shows how a set of genetic differences in those with bipolar disorder can lead to specific psychological dysfunction in synapses in the brain. The findings could help improve diagnosis of the disorder and help develop new treatments for BD.
